Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LMP7-IN-1 may used in the research of inflammatory and autoimmune diseases, neurodegenerative diseases, proliferative diseases and cancer, is an inhibitor of immunoproteasome (LMP7).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 893.00 | |
50 mg | 10-14 weeks | $ 1,160.00 | |
100 mg | 10-14 weeks | $ 1,860.00 |
Description | LMP7-IN-1 may used in the research of inflammatory and autoimmune diseases, neurodegenerative diseases, proliferative diseases and cancer, is an inhibitor of immunoproteasome (LMP7). |
In vitro | LMP7-IN-1 may used in the research of inflammatory and autoimmune diseases, neurodegenerative diseases, proliferative diseases and cancer[1]. |
Synonyms | LMP7-IN-1 |
Molecular Weight | 329.16 |
Formula | C17H20BNO5 |
CAS No. | 2285330-15-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (759.51 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
M3258 2285330-15-4 Proteases/Proteasome Ubiquitination Proteasome M-3258 M 3258 LMP7-IN-1 inhibitor inhibit